04/23/2024
4:16 PM | Recursion Pharmaceuticals (Filer)
| Form DEFA14A | |
04/23/2024
4:29 PM | Recursion Pharmaceuticals (Filer)
| Form ARS | |
04/18/2024
4:12 PM | Recursion Pharmaceuticals (Issuer)
Secora Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/18/2024
4:12 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2024
3:18 PM | Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/16/2024
3:55 PM | Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
| Form 144/A | |
04/16/2024
3:15 PM | Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
04/16/2024
7:04 AM | Recursion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/05/2024
4:44 PM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2024
10:13 AM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/04/2024
9:39 AM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/03/2024
4:42 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
4:42 PM | Burrell Terry-Ann (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
4:43 PM | Dar Zavain (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
4:43 PM | CHAVEZ R. MARTIN (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
4:43 PM | Li Dean Y (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
10:09 AM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/02/2024
4:01 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/01/2024
5:40 PM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
11:43 AM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/25/2024
5:39 PM | Marriott Tina (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
4:38 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
3:35 PM | Marriott Tina (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/19/2024
3:35 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/14/2024
6:28 PM | Recursion Pharmaceuticals (Issuer)
Secora Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2024
3:48 PM | Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/12/2024
3:32 PM | Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/08/2024
6:08 PM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
5:53 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
4:39 PM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/06/2024
3:59 PM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024
7:25 AM | Recursion Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/23/2024
6:22 PM | Marriott Tina (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
5:13 PM | Marriott Tina (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2024
4:37 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2024
3:29 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/16/2024
6:57 PM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
6:58 PM | Marriott Tina (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
6:59 PM | Recursion Pharmaceuticals (Issuer)
Secora Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
5:00 PM | Recursion Pharmaceuticals (Issuer)
Secora Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
5:55 PM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Move Your Money Before May 22 (Ad) The SIX WORDS That Could Destroy America... And The Value of Your Savings.
He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals.  Here's where Dr. David Eifrig says to move your money immediately. |
02/13/2024
6:00 PM | Marriott Tina (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
6:01 PM | Recursion Pharmaceuticals (Issuer)
Secora Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
6:03 PM | Mauro David J (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2024
11:21 AM | ARK Investment Management LLC (Filed by)
Recursion Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/09/2024
4:34 PM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/09/2024
8:49 AM | FMR LLC (Filed by)
Recursion Pharmaceuticals (Subject)
| Form SC 13G | |
02/08/2024
5:54 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:40 PM | Recursion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/29/2024
5:52 PM | Larson Tina Marriott (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2024
4:25 PM | BlackRock Inc. (Filed by)
Recursion Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/29/2024
3:00 PM | ARK Investment Management LLC (Filed by)
Recursion Pharmaceuticals (Subject)
| Form SC 13G | |
01/25/2024
5:13 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
9:13 AM | Recursion Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G | |
01/23/2024
3:20 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/18/2024
5:37 PM | Recursion Pharmaceuticals (Issuer)
Secora Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2024
5:39 PM | Recursion Pharmaceuticals (Issuer)
Virani Shafique (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
3:34 PM | Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2024
8:55 AM | Recursion Pharmaceuticals (Subject)
Virani Shafique (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/11/2024
5:50 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/11/2024
5:51 PM | Li Dean Y (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
4:02 PM | Li Dean Y (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/09/2024
3:14 PM | Li Dean Y (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/09/2024
3:15 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024
6:59 AM | Recursion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/05/2024
7:03 PM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
5:11 PM | Li Dean Y (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
5:11 PM | Dar Zavain (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
5:11 PM | CHAVEZ R. MARTIN (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2024
3:58 PM | Larson Tina Marriott (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2023
4:48 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2023
3:11 PM | Larson Tina Marriott (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/26/2023
3:32 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/20/2023
7:01 AM | Recursion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/19/2023
6:22 PM | Recursion Pharmaceuticals (Issuer)
Virani Shafique (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
5:44 PM | Dar Zavain (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/15/2023
11:08 AM | Recursion Pharmaceuticals (Subject)
Virani Shafique (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/15/2023
7:38 AM | Recursion Pharmaceuticals (Filer)
| Form 424B7 | |
12/15/2023
7:41 AM | Recursion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/14/2023
5:51 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/14/2023
5:53 PM | Recursion Pharmaceuticals (Issuer)
Secora Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/14/2023
12:58 PM | Dar Zavain (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/13/2023
10:15 AM | Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/12/2023
3:24 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/12/2023
9:46 AM | Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/08/2023
4:22 PM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2023
1:57 PM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/30/2023
4:41 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/28/2023
3:25 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/17/2023
4:52 PM | Recursion Pharmaceuticals (Issuer)
Virani Shafique (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/17/2023
4:53 PM | Larson Tina Marriott (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad) Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow. Click here for your free guide |
11/17/2023
4:50 PM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/16/2023
5:54 PM | Recursion Pharmaceuticals (Issuer)
Secora Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/16/2023
5:55 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/16/2023
11:28 AM | Larson Tina Marriott (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/15/2023
11:41 AM | Recursion Pharmaceuticals (Subject)
Virani Shafique (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/15/2023
10:12 AM | Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2023
12:09 PM | Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/09/2023
7:03 AM | Recursion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/09/2023
7:08 AM | Recursion Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
